During our Virtual Panel Series discussion on January 13th, Dr. Marjut Salokannel docent joined us to discuss the topic…
During our Virtual Panel Series discussion on January 13th, Dr. Ana Nordberg joined us to discuss the topic…
During our Virtual Panel Series discussion on January 13th, Dr. Mahsa Shabani joined us to discuss…
Prof Kjetil Tasken speaks about CAR T-cells therapy and inequalities in cancer treatment
Prof. Magnus Essand, of Uppsala University, joined us for our Virtual Panel Discussion on December 17th.
During our Virtual Panel Series discussion on December 17th, our expert panellist’s discussed, Immuno-oncology….
Prof. Rob Jones, of Cancer Research UK Glasgow Clinical Trials Unit, speaks about the next steps that need to be taken for clinical trials to progress
Dr. Capucine Baldini, of Gustave Roussy, speaks about how Gustave Roussy dealt with the first and second waves of the pandemic.
Eibhlin Mulroe spoke to PMF about the difficulties of performing clinical trials in hospitals during the first and second wave of the pandemic.
Dr Capucine Baldini, Medical Oncologist, Drug Development (DITEP), Institut de Cancérologie Gustave Roussy, will be joining us for our next Virtual Panel Series
Prof. Rob Jones gives us insight into the work being done at Cancer Research UK Glasgow Clinical Trials Unit
Dr. Julien Masliah Planchon, of Institut Curie, gave interesting insight into Institut Curie’s use of Molecular Tumour Boards.
Dr. Maud Kamal, of Institut Curie, joined us for our Virtual Panel Series discussions on November 12, 2020
Our panelist’s delved into the topic of data integrity and how important it is in today’s research and healthcare settings.
In this clip from our Virtual Panel Series session on November 12, 2020, Dr. David Tamborero, of Karolinska Institutet, answered an audience question…
Director of Precision Medicine Forum, Steve Coldicott, realised that there was a need for researchers to be able to share their scientific posters online.
In this clip from our Virtual Panel Series discussion on October 22, 11am EST, Dr. Maurie Markman, talks about the role science plays in encouraging patients to return to hospitals.
Dorothy Erlanger, Chair of the Patient Advocate Committee at the National Cancer Institute, spoke about the difficulties facing patient treatment during the pandemic.
During our Virtual Panel Series discussion on October 22 at 11am EST, we got the perspective of how the pandemic is being dealt with in the US.
For our first Virtual Panel Series session, our expert panellist’s were discussing the impact Covid-19 has had on Cancer treatment and screening.
During our first Virtual Panel Series Discussion on October 22, 2020, our expert panellist’s were speaking about the impact Covid-19 has had on cancer treatment and screening.
The University of Oxford Partners with King Abdulaziz University to set up a new Centre for Artificial Intelligence and Precision MedicineView Post
UK Government launches NEW National Genomics Healthcare StrategyView Post
Pricey Precision Medicine Often Financially Toxic For Cancer PatientsView Post
YOU CAN’T HELP EVERYBODY BUT YOU CAN MAKE SURE YOU HELP THE RIGHT PEOPLEView Post
TO LIVE TOGETHER IS THE ESSENCE OF LIFEView Post
EVERY PATIENT IS UNIQUEView Post
THERE IS NO PRECISION MEDICINE WITHOUT COLLABORATIONView Post
PRECISION MEDICINE SHOULD BECOME NORMAL TO IMPLEMENT IN PRIMARY CARE PRACTICEView Post
WE NEED TO BREAK DOWN THE BARRIERS THAT ARE HOLDING BACK INNOVATIONView Post
DATA ANALYSIS, AGGREGATION AND MANAGEMENT HAVE AN ESSENTIAL ROLE TO PLAY IN GAINING INSIGHTS AND WISDOM FROM GENOMIC DATAView Post
To help patients is the goal of everythingView Post
IT’S ALL ABOUT COLLABORATION – ALONE WE CAN’T DO ANYTHINGView Post
Precision medicine and what it means to be humanView Post
Sweden’s strong tradition in genetic technologyView Post
Pharmacogenetics the Dutch wayView Post
We need to change our expectationsView Post
Published on Apr 25, 2016 The 100,000 Genomes Project is creating the world’s largest genome sequencing project for cancers and rare diseases, and has the potential to transform the diagnosis and treatment of cancers and rare diseases. As Data Management Partner for this transformative project, ICON is using its world-class capabilities to validate and securely manage the large, complex data …
Published on May 31, 2016 At Roche Pharma Research and Early Development, we are working on a novel form of engineered antibodies for cancer immunotherapy that we call T-cell bispecific antibodies. We consider them match-makers between T-Cells and cancer cells. With two handles, they recognize specific markers on the surface of cancer cells. A third handle is designed to hook …
Link via Dana-Farber Cancer Institute How does immunotherapy fight cancer? If you take the brakes off the immune system, you can unleash an attack on cancer cells. That’s the theory behind PD-1/PD-L1, a vitally important immunotherapy discovery illustrated in this video.
Link via Winship Cancer Institute of Emory University Understanding cancer cell behavior is a fundamental step toward advancing precision medicine. Winship’s Adam Marcus, PhD, shows how his lab is isolating and studying the behavior “leader” cells that may be the key to cancer metastasis.
On the one year anniversary of the launch of the Precision Medicine Initiative, President Obama participates in a panel discussion moderated by Dr. James Hamblin of The Atlantic on the importance of PMI in South Court Auditorium at the White House, February 25, 2016. “Doctors have always recognized that every patient is unique, and doctors have always tried to tailor …
Watch this Newfoundlanders story about how genomics is offering him protection against a potentially lethal disease.
Precision medicine aims to collect, connect, and apply vast amounts of data and information about our health to help guide more precise and predictive medicine worldwide. Learn more at http://precisionmedicine.ucsf.edu/
Precision medicine is the practice of using a cancer cell’s DNA to guide therapy. Learn how scientists have used precision medicine to treat rare brain tumors. This video was produced in collaboration with Malak Abed and her team in Boston.
Published on Nov 4, 2015 In a study published in Nature Communications, Dr. Muhammed Murtaza, who holds a joint appointment at Mayo Clinic and Translational Genomics Research Institute (TGEN), and colleagues, describe an extensive comparison between biopsy results and analysis of ctDNA in a patient with breast cancer. In the following video, Dr. Murtaza describes how circulating tumor DNA in …
Since the discovery of DNA’s fundamental role in building and sustaining life, scientists have dreamed of having the ability to easily edit DNA in very precise ways. This video explores how a group of scientists made a major breakthrough in understanding the bacterial immune response, called the CRISPR/Cas system, and discovered a way to utilize this system to create a …